Sign inJoin waitlistJoin the waitlist

Doug Simonetto

Program Director · Mayo Clinic College of Medicine and Science

Credentials: · · · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Transplant Hepatology
Mayo Clinic College of Medicine and Science
2019–2020
Gastroenterology
Mayo Clinic College of Medicine and Science
2016–2019
Internal Medicine
Mayo Clinic College of Medicine and Science
2013–2016
MDFederal University of Health Sciences of Porto Alegre
2010–2013
Faculdade de Medicina da Universidade Federal do Rio Grande do Sul
2003–2007

Research

AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis
Hepatology · 2024 · 370 citations
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
New England Journal of Medicine · 2021 · 369 citations
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population
Hepatology Communications · 2022 · Last of 9 authors · Corresponding · 304 citations

Vijay Shah
76 papers
Patrick Kamath
74 papers
Joseph Ahn
20 papers · 10 as a fellow
Ashwani Singal
17 papers
PR
Puru Rattan
17 papers · 17 as a fellow
RA
Ramon Bataller Alberola
17 papers
DP
Daniel Penrice
15 papers · 14 as a resident
GG
Guadalupe Garcia-Tsao
14 papers
Andrew Allegretti
12 papers
Sumeet Asrani
12 papers
Alice De Moraes
11 papers
Arun Sanyal
11 papers

Grants

Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $1.9M · Mayo Clinic Rochester
2021–2027
Randomized Placebo Controlled Pilot Trial to Determine the Efficacy of an IL22 Agonist (F-652) in Patients with Alcoholic Hepatitis
National Institute on Alcohol Abuse and Alcoholism · U01
PI · $375K · Mayo Clinic Rochester
2018–2024

Clinical trials

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
Principal investigator · Completed
Mayo Clinic
2024–2026
A Study to Detect Advanced Liver Disease Via AI-enabled Electrocardiogram
Principal investigator · Completed
Mayo Clinic
2023–2025
Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration
Principal investigator · Completed
Mayo Clinic
2022–2023
Acamprosate Safe to Use in Individuals With Liver Disease.
Principal investigator · Completed · Phase 2
Mayo Clinic
2020–2022